Literature DB >> 9767459

Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection.

T F Pais1, R A Silva, B Smedegaard, R Appelberg, P Andersen.   

Abstract

The delayed-type hypersensitivity (DTH) to purified protein derivative (PPD) test has been used to infer about protective immunity to Mycobacterium tuberculosis and to diagnose tuberculosis. We showed that in memory tuberculosis-immune mice both DTH to PPD and resistance to M. tuberculosis could be effectively elicited in the footpad and both reactions led to the accumulation of reactive T cells in the regional lymph nodes with a CD4+ phenotype and characterized by the secretion of high levels of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) and no IL-4. By adoptive transfer into nude mice of highly purified CD4+ T cells harvested during the recall of protective immunity it was confirmed that this population mediated both manifestations. However, the specificity of the T cells recruited during these processes were found to differ markedly; T cells involved in protection to a challenge with live tuberculosis bacilli recognized predominantly low-mass culture filtrate antigens below 15 000 MW, while cells recruited during DTH to PPD were directed to molecular mass fractions between 15 000 and 31 000. Using single purified antigens we showed that the latter cells recognized the secreted mycobacterial protein Ag85B and the heat-shock proteins, DnaK and GroEL. Protective T cells, in contrast, were characterized by a very high frequency of T cells directed to the ESAT-6 peptide 1-20.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767459      PMCID: PMC1364378          DOI: 10.1046/j.1365-2567.1998.00561.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  The first clinical trial of streptomycin in human tuberculosis.

Authors:  K H PFUETZE; M M PYLE; H C HINSHAW; W H FELDMAN
Journal:  Am Rev Tuberc       Date:  1955-05

Review 2.  Resistance to intracellular infection.

Authors:  G B Mackaness
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

3.  Failure of killed Listeria monocytogenes vaccine to produce protective immunity.

Authors:  C H von Koenig; H Finger; H Hof
Journal:  Nature       Date:  1982-05-20       Impact factor: 49.962

4.  Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.

Authors:  P E Fine; J A Sterne; J M Pönnighaus; R J Rees
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321

5.  Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis.

Authors:  A D Roberts; M G Sonnenberg; D J Ordway; S K Furney; P J Brennan; J T Belisle; I M Orme
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

6.  Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice.

Authors:  P Andersen; A B Andersen; A L Sørensen; S Nagai
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

7.  Proteins released from Mycobacterium tuberculosis during growth.

Authors:  P Andersen; D Askgaard; L Ljungqvist; J Bennedsen; I Heron
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

8.  Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines.

Authors:  I M Orme
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

9.  Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis.

Authors:  C H Ladel; C Blum; A Dreher; K Reifenberg; S H Kaufmann
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

Review 10.  The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis.

Authors:  H G Wiker; M Harboe
Journal:  Microbiol Rev       Date:  1992-12
View more
  18 in total

1.  Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.

Authors:  A Jepson; A Fowler; W Banya; M Singh; S Bennett; H Whittle; A V Hill
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection.

Authors:  T Shigenaga; A M Dannenberg; D B Lowrie; W Said; M J Urist; H Abbey; B H Schofield; P Mounts; K Sugisaki
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

3.  Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.

Authors:  R K Katial; J Hershey; T Purohit-Seth; J T Belisle; P J Brennan; J S Spencer; R J Engler
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.

Authors:  A S Mustafa; F A Shaban; A T Abal; R Al-Attiyah; H G Wiker; K E Lundin; F Oftung; K Huygen
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation.

Authors:  André Kübler; Brian Luna; Christer Larsson; Nicole C Ammerman; Bruno B Andrade; Marlene Orandle; Kevin W Bock; Ziyue Xu; Ulas Bagci; Daniel J Mollura; John Marshall; Jay Burns; Kathryn Winglee; Bintou Ahmadou Ahidjo; Laurene S Cheung; Mariah Klunk; Sanjay K Jain; Nathella Pavan Kumar; Subash Babu; Alan Sher; Jon S Friedland; Paul T G Elkington; William R Bishai
Journal:  J Pathol       Date:  2014-10-06       Impact factor: 7.996

6.  Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity.

Authors:  Dongmei Lu; Lucila Garcia-Contreras; Pavan Muttil; Danielle Padilla; Ding Xu; Jian Liu; Miriam Braunstein; David N McMurray; Anthony James Hickey
Journal:  AAPS J       Date:  2010-04-27       Impact factor: 4.009

7.  Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.

Authors:  Lise Brandt; Joana Feino Cunha; Anja Weinreich Olsen; Ben Chilima; Penny Hirsch; Rui Appelberg; Peter Andersen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  Blood Cells and Interferon-Gamma Levels Correlation in Latent Tuberculosis Infection.

Authors:  Iukary Takenami; Camila Loureiro; Almério Machado; Krisztina Emodi; Lee W Riley; Sérgio Arruda
Journal:  ISRN Pulmonol       Date:  2013

9.  Evaluation of memory immune response to mycobacterium extract among household contact of tuberculosis cases.

Authors:  Y V N Cavalcanti; V R A Pereira; L C Reis; A L G Ramos; C F Luna; E J M Nascimento; N Lucena-Silva
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

10.  Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy.

Authors:  Doreen Manuela Floss; Michael Mockey; Galliano Zanello; Damien Brosson; Marie Diogon; Roger Frutos; Timothée Bruel; Valérie Rodrigues; Edwin Garzon; Claire Chevaleyre; Mustapha Berri; Henri Salmon; Udo Conrad; Laurence Dedieu
Journal:  J Biomed Biotechnol       Date:  2010-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.